Quantitative Spectrochip-Coupled Lateral Flow Immunoassay Demonstrates Clinical Potential for Overcoming Coronavirus Disease 2019 Pandemic Screening Challenges

Quantitative Spectrochip-Coupled Lateral Flow Immunoassay Demonstrates Clinical Potential for Overcoming Coronavirus Disease 2019 Pandemic Screening Challenges

As coronavirus disease 2019 (COVID-19) continues to spread around the world, the establishment of decentralized severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) diagnostics and point-of-care testing is invaluable. While polymerase chain reaction (PCR) has been the gold standard for COVID...

Full description

Bibliographic Details
Main Authors: Kai-Feng Hung, Chih-Hsing Hung, Chitsung Hong, Szu-Chia Chen, Yi-Chen Sun, Jyun-Wei Wen, Chao-Hung Kuo, Cheng-Hao Ko, Chao-Min Cheng
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Micromachines
Subjects:
coronavirus disease 2019 (COVID-19)
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
lateral flow immunoassay
reflectance spectrum
detection limit
Online Access:https://www.mdpi.com/2072-666X/12/3/321

Internet

https://www.mdpi.com/2072-666X/12/3/321

Similar Items